CN106822530A - A kind for the treatment of chronic pancreatitis medicine - Google Patents

A kind for the treatment of chronic pancreatitis medicine Download PDF

Info

Publication number
CN106822530A
CN106822530A CN201510905886.9A CN201510905886A CN106822530A CN 106822530 A CN106822530 A CN 106822530A CN 201510905886 A CN201510905886 A CN 201510905886A CN 106822530 A CN106822530 A CN 106822530A
Authority
CN
China
Prior art keywords
parts
medicine
root
chronic pancreatitis
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510905886.9A
Other languages
Chinese (zh)
Inventor
季延滨
李涛
侯继明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chi Sheng (tianjin) Biological Technology Co Ltd
Original Assignee
Chi Sheng (tianjin) Biological Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chi Sheng (tianjin) Biological Technology Co Ltd filed Critical Chi Sheng (tianjin) Biological Technology Co Ltd
Priority to CN201510905886.9A priority Critical patent/CN106822530A/en
Publication of CN106822530A publication Critical patent/CN106822530A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention provides a kind for the treatment of chronic pancreatitis medicine, the medicine includes the composition of following weight portion:9 parts of rhodiola root, 6 parts of the root of herbaceous peony, 6 parts of Chinese yam, 3 parts of glutinous rehmannia, 1 part of great Ye Lepisorus thunbergianus (Kaulf.) Chings, 1 part of RADIX PSAMMOSILENE, 0.5 part of indian azalea leaf, 0.5 part of Flos Hibisci Rosae-Sinensis.The honeysuckle of the scaly holly root, the ilecis,fructus of 2 weight portions or 1 weight portion of 2 weight portions can also be further added on this basis.The present invention has obtained above pharmaceutical formulation by the rational Design on Plane to traditional Chinese medicine ingredients, and the medicine protrudes chronic pancreatitis curative effect, works comparatively fast, and efficient and cure rate is superior to prior art.

Description

A kind for the treatment of chronic pancreatitis medicine
Technical field
The present invention relates to medical sanitary technology field, and in particular to a kind for the treatment of chronic pancreatitis medicine.
Background technology
Chronic pancreatitis is, due to the infringement of pancreatic parenchmal progressive and fibrosis caused by the factors such as disease of biliary tract or alcoholism, often to be reduced or atrophy with calcification, false cyst and islet cells.Be mainly shown as stomachache, become thin, malnutritive, diarrhoea or stearrhea, the later stage may occur in which abdominal mass, jaundice and diabetes etc..The treating chronic pancreatitis medicine of prior art has unsatisfactory curative effect, work slower technical problem, so as to significantly limit the therapeutic effect of the disease.
The content of the invention
It is contemplated that for the technological deficiency of prior art, there is provided a kind for the treatment of chronic pancreatitis medicine, to solve, treating chronic pancreatitis curative effect of medication in the prior art is not good, work slower technical problem.
To realize above technical purpose, the present invention uses following technical scheme:
A kind for the treatment of chronic pancreatitis medicine, including following weight portion composition:9 parts of rhodiola root, 6 parts of the root of herbaceous peony, 6 parts of Chinese yam, 3 parts of glutinous rehmannia, 1 part of great Ye Lepisorus thunbergianus (Kaulf.) Chings, 1 part of RADIX PSAMMOSILENE, 0.5 part of indian azalea leaf, 0.5 part of Flos Hibisci Rosae-Sinensis.
Preferably, also including the scaly holly root of 2 weight portions.
Preferably, also including the ilecis,fructus of 2 weight portions.
Preferably, also including the honeysuckle of 1 weight portion.
Preferably, the formulation of the medicine is powder.
Preferably, the formulation of the medicine is pill.
The present invention is by the rational Design on Plane to traditional Chinese medicine ingredients, above pharmaceutical formulation is obtained, mentioned component respectively has the pharmacological properties of its own, although not finding that mentioned component individually has therapeutic effect to chronic pancreatitis in the prior art, but the present invention is found surprisingly that after being integrated and optimizing consumption proportion, resulting pharmaceutical composition has prominent therapeutic effect to chronic pancreatitis, while working very fast and having no side effect.Positive discovery, develops treating chronic pancreatitis medicine of the invention based on more than, and its determined curative effect, clinical trial work well, great industrialization prospect.
Specific embodiment
Specific embodiment of the invention will be below described in detail.In order to avoid excessive unnecessary details, be will not be described in detail to belonging to known structure or function in the examples below.In addition to being defined, technology used and scientific terminology have the identical meanings being commonly understood by with those skilled in the art of the invention in following examples.
Embodiment 1
A kind for the treatment of chronic pancreatitis medicine, is composed of the following components in parts by weight:9 parts of rhodiola root, 6 parts of the root of herbaceous peony, 6 parts of Chinese yam, 3 parts of glutinous rehmannia, 1 part of great Ye Lepisorus thunbergianus (Kaulf.) Chings, 1 part of RADIX PSAMMOSILENE, 0.5 part of indian azalea leaf, 0.5 part of Flos Hibisci Rosae-Sinensis, 2 parts of scaly holly root, 2 parts of ilecis,fructus, 1 part of honeysuckle.Its formulation is powder.
Embodiment 2
A kind for the treatment of chronic pancreatitis medicine, is composed of the following components in parts by weight:9 parts of rhodiola root, 6 parts of the root of herbaceous peony, 6 parts of Chinese yam, 3 parts of glutinous rehmannia, 1 part of great Ye Lepisorus thunbergianus (Kaulf.) Chings, 1 part of RADIX PSAMMOSILENE, 0.5 part of indian azalea leaf, 0.5 part of Flos Hibisci Rosae-Sinensis, 2 parts of scaly holly root, 1 part of honeysuckle.Its formulation is pill.
Embodiment 3
A kind for the treatment of chronic pancreatitis medicine, is composed of the following components in parts by weight:9 parts of rhodiola root, 6 parts of the root of herbaceous peony, 6 parts of Chinese yam, 3 parts of glutinous rehmannia, 1 part of great Ye Lepisorus thunbergianus (Kaulf.) Chings, 1 part of RADIX PSAMMOSILENE, 0.5 part of indian azalea leaf, 0.5 part of Flos Hibisci Rosae-Sinensis, 2 parts of ilecis,fructus, 1 part of honeysuckle.Its formulation is pill.
Embodiment 4
A kind for the treatment of chronic pancreatitis medicine, is composed of the following components in parts by weight:9 parts of rhodiola root, 6 parts of the root of herbaceous peony, 6 parts of Chinese yam, 3 parts of glutinous rehmannia, 1 part of great Ye Lepisorus thunbergianus (Kaulf.) Chings, 1 part of RADIX PSAMMOSILENE, 0.5 part of indian azalea leaf, 0.5 part of Flos Hibisci Rosae-Sinensis, 2 parts of scaly holly root.Its formulation is powder.
Embodiment 5
A kind for the treatment of chronic pancreatitis medicine, is composed of the following components in parts by weight:9 parts of rhodiola root, 6 parts of the root of herbaceous peony, 6 parts of Chinese yam, 3 parts of glutinous rehmannia, 1 part of great Ye Lepisorus thunbergianus (Kaulf.) Chings, 1 part of RADIX PSAMMOSILENE, 0.5 part of indian azalea leaf, 0.5 part of Flos Hibisci Rosae-Sinensis.
Embodiments of the invention have been described in detail above, but the content is only presently preferred embodiments of the present invention, is not intended to limit the invention.All any modification, equivalent and improvement made in application range of the invention etc., should be included within the scope of the present invention.

Claims (6)

1. a kind for the treatment of chronic pancreatitis medicine, it is characterised in that the composition including following weight portion:Rhodiola root 9 parts, 6 parts of the root of herbaceous peony, 6 parts of Chinese yam, 3 parts of glutinous rehmannia, 1 part of great Ye Lepisorus thunbergianus (Kaulf.) Chings, 1 part of RADIX PSAMMOSILENE, azalea 0.5 part of leaf, 0.5 part of Flos Hibisci Rosae-Sinensis.
2. medicine according to claim 1, it is characterised in that also including the scaly holly root of 2 weight portions.
3. medicine according to claim 1, it is characterised in that also including the ilecis,fructus of 2 weight portions.
4. medicine according to claim 1, it is characterised in that also including the honeysuckle of 1 weight portion.
5. medicine according to claim 1, it is characterised in that the formulation of the medicine is powder.
6. medicine according to claim 1, it is characterised in that the formulation of the medicine is pill.
CN201510905886.9A 2015-12-07 2015-12-07 A kind for the treatment of chronic pancreatitis medicine Pending CN106822530A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510905886.9A CN106822530A (en) 2015-12-07 2015-12-07 A kind for the treatment of chronic pancreatitis medicine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510905886.9A CN106822530A (en) 2015-12-07 2015-12-07 A kind for the treatment of chronic pancreatitis medicine

Publications (1)

Publication Number Publication Date
CN106822530A true CN106822530A (en) 2017-06-13

Family

ID=59151797

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510905886.9A Pending CN106822530A (en) 2015-12-07 2015-12-07 A kind for the treatment of chronic pancreatitis medicine

Country Status (1)

Country Link
CN (1) CN106822530A (en)

Similar Documents

Publication Publication Date Title
HRP20192168T1 (en) Transient protection of normal cells during chemotherapy
MX356702B (en) Very low-dosed solid oral dosage forms for hrt.
CN101721616A (en) Medicine for stopping bleeding
CN106822530A (en) A kind for the treatment of chronic pancreatitis medicine
CN102697868A (en) Medicine capable of regulating immunity and curing lupus erythematosus, urticaria and psoriasis
CN101757458A (en) Traditional Chinese preparation for treating facial nerve spasm
CN106860728A (en) A kind of reflux esophagitis medicine
CN103285099A (en) Traditional Chinese medicine mixture for treatment of constipation
CN106860676A (en) A kind of hypertension therapeutic medicine
CN106860742A (en) A kind of fatty liver medicine
CN106860716A (en) A kind of hyperthyroidism medicine
CN106860798A (en) A kind of lupus erythematosus zhiliao medicine
CN106860632A (en) A kind of remedy for bronchial asthma thing
CN106822624A (en) A kind of chronic renal failure medicine
CN106880703A (en) A kind of pulmonary emphysema medicine
CN106266658A (en) A kind of formula controlling puerperal night sweating
CN106822626A (en) A kind for the treatment of of chronic medicine
CN1682911A (en) Chinese medicine for treating cancer
CN106852962A (en) A kind of gout treatment medicine
CN106822625A (en) A kind of pyelonephritis medicine
CN106860553A (en) A kind of osteoporosis therapy medicine
CN106822693A (en) A kind of therapeutics of iron deficiency anemia medicine
CN106728182A (en) A kind of pig epidemic diarrhea medicine
CN106614828A (en) Disinfection and sterilization incense for poultry
CN106822383A (en) A kind of dysmenorrhea treatment medicine

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20170613

WD01 Invention patent application deemed withdrawn after publication